You are here

  • Home
  • Archive
  • Volume 9, Issue 6
  • Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial

Article info

Article menu

Download PDFPDF

XML
Neurology
Protocol
Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial

Authors

  • Anne Marit Solheim Department of Neurology, Sørlandet Hospital, Kristiansand, Norway Department of Clinical Medicine, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Unn Ljøstad Department of Neurology, Sørlandet Hospital, Kristiansand, Norway Department of Clinical Medicine, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Åse Mygland Department of Neurology, Sørlandet Hospital, Kristiansand, Norway Department of Clinical Medicine, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Anne Marit Solheim; anne.marit.solheim{at}sshf.no
View Full Text

Citation

Solheim AM, Ljøstad U, Mygland Å
Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial
BMJ Open 2019;9:e027083. doi: 10.1136/bmjopen-2018-027083

Publication history

  • Received October 5, 2018
  • Revised April 16, 2019
  • Accepted April 17, 2019
  • First published June 14, 2019.
Online issue publication 
August 05, 2023
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.